Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-04-007729
Filing Date
2004-03-12
Accepted
2004-03-12 17:00:22
Documents
9
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2129953z10-k.htm 10-K 1826503
3 EXHIBIT 4.1 a2129953zex-4_1.htm EX-4.1 17530
4 EXHIBIT 10.4 a2129953zex-10_4.htm EX-10.4 5444
5 EXHIBIT 21.1 a2129953zex-21_1.htm EX-21.1 9826
6 EXHIBIT 23.1 a2129953zex-23_1.htm EX-23.1 2769
7 EXHIBIT 31.1 a2129953zex-31_1.htm EX-31.1 8845
8 EXHIBIT 31.2 a2129953zex-31_2.htm EX-31.2 8897
9 EXHIBIT 32.1 a2129953zex-32_1.htm EX-32.1 5525
10 EXHIBIT 32.2 a2129953zex-32_2.htm EX-32.2 5666
  Complete submission text file 0001047469-04-007729.txt   1893426
Mailing Address 311 BONNIE CIRCLE CORONA CA 92880
Business Address 311 BONNIE CIRCLE CORONA CA 92880 9092701400
WATSON PHARMACEUTICALS INC (Filer) CIK: 0000884629 (see all company filings)

EIN.: 953872914 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-13305 | Film No.: 04666788
SIC: 2834 Pharmaceutical Preparations